We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Janssen Submits IV Simponi For Moderate to Severe RA
Janssen Submits IV Simponi For Moderate to Severe RA
September 21, 2012
Janssen Biotech has submitted a BLA seeking approval of an IV formulation of Simponi to treat adults with moderate to severe rheumatoid arthritis (RA).